Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov;42(11):4759-4765.
doi: 10.1007/s10072-021-05480-z. Epub 2021 Jul 22.

A novel homozygous variant in JAM3 gene causing hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts (HDBSCC) with neonatal onset

Affiliations
Case Reports

A novel homozygous variant in JAM3 gene causing hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts (HDBSCC) with neonatal onset

Domenico Umberto De Rose et al. Neurol Sci. 2021 Nov.

Abstract

Background: JAM3 gene, located on human chromosome 11q25, encodes a member of the junctional adhesion molecule (JAM) family. Mutations of this gene are associated with hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts (HDBSCC).

Case report: Herein, we present a newborn male with a prenatal suspicion of bilateral cataracts but without fetal ultrasound findings of cortical malformations. He was postnatally diagnosed with a clinical picture of HDBSCC and Early-onset Developmental and Epileptic Encephalopathy (DEE), associated to a homozygous variant of JAM3 gene.

Conclusion: Identification of this variant in affected individuals has implications for perinatal and postnatal management and genetic counseling. To the best of our knowledge, this is the first case reported of a child with a JAM3 variant in Italy, from a different ethnic background than the other reported children until now (Saudi Arabian, Turkish, Afghani, and Moroccan origin). JAM3 screening could be requested in prenatal diagnosis of fetal congenital cataracts and included in Next-Generation DNA Sequencing panels.

Keywords: JAM3; Seizures; Cerebral hemorrhages; Cataracts; Neonate; Infant; COL4A1.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Axial T2-weighted (A) and susceptibility weighted imaging (B) of brain MRI showed severe intraventricular hemorrhage and bilateral multiple intraparenchymal hemorrhages, prevailing in the left hemisphere, and enlargement of the posterior horns of the lateral ventricles. Coronal T2-weighted (C) showed multiple cysts in the frontal periventricular white matter. Sagittal T1-weighted (D) revealed also a large intraventricular clot in the III ventricle and hypoplasia of cerebellar vermis. Multiple periventricular calcifications (arrows) were demonstrated on phase axial susceptibility weighted image (E), on T1-weighted (F) image, and on corresponding axial CT (G). There was no evidence of venous thrombosis and vascular malformation on MR venogram (H) and time of flight angiography (not shown)
Fig. 2
Fig. 2
(A) Sanger sequencing confirmed the homozygous variation, c.690 T > G, in the proband. (B and C) Sanger sequencing shown that the parents were both carrying the heterozygous variation
Fig. 3
Fig. 3
The patient during NICU stay (AB), at 12 months (C) and at 24 months (D)
Fig. 4
Fig. 4
Axial (AE) and coronal (F-L) T2-weighted images of serial brain MRI: (A,F) 1 month of life, (BG) 3 months of life, (CH) 4 months of life, (DI) 15 months of life, (EL) 2 years of life. Serial MRI scans showed porencephalic cystic evolution and reduced white-matter volume (indicative of destructive changes), and consensual gradual worsening of ventricular dilatation unless a ventriculoperitoneal shunt was implanted at 4 months of life. Last two MRI exams (D-I and E-L) showed a plastic re-organization of porencephalic cysts and lateral ventricles with reduction of signs of cerebrospinal fluid’s decompensation

References

    1. Arrate MP, Rodriguez JM, Tran TT, et al. Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem. 2001;276:45826–45832. doi: 10.1074/jbc.M105972200. - DOI - PubMed
    1. Liang TW, Chiu HH, Gurney A, et al. Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM 3. J Immun. 2002;168:1618–1626. doi: 10.4049/jimmunol.168.4.1618. - DOI - PubMed
    1. Santoso S, Sachs UJH, Kroll H, et al. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J Exp Med. 2002;196:679–691. doi: 10.1084/jem.20020267. - DOI - PMC - PubMed
    1. Mochida GH, Ganesh VS, Felie JM, et al. A homozygous mutation in the tight-junction protein JAM3 causes hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Am J Hum Genet. 2010;87:882–889. doi: 10.1016/j.ajhg.2010.10.026. - DOI - PMC - PubMed
    1. Akawi NA, Canpolat FE, White SM, et al. Delineation of the clinical, molecular and cellular aspects of novel JAM3 mutations underlying the autosomal recessive hemorrhagic destruction of the brain, subependymal calcification, and congenital cataracts. Hum Mutat. 2013;34:498–505. doi: 10.1002/humu.22263. - DOI - PMC - PubMed

Publication types

Substances